1-117896840-G-A
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_017686.4(GDAP2):c.946C>T(p.Gln316Ter) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000671 in 1,609,350 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000067 ( 0 hom. )
Consequence
GDAP2
NM_017686.4 stop_gained
NM_017686.4 stop_gained
Scores
5
1
1
Clinical Significance
Conservation
PhyloP100: 9.13
Genes affected
GDAP2 (HGNC:18010): (ganglioside induced differentiation associated protein 2) Predicted to act upstream of or within response to retinoic acid. Located in lysosomal membrane. Implicated in autosomal recessive spinocerebellar ataxia 27. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 1-117896840-G-A is Pathogenic according to our data. Variant chr1-117896840-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 624618.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr1-117896840-G-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GDAP2 | NM_017686.4 | c.946C>T | p.Gln316Ter | stop_gained | 8/14 | ENST00000369443.10 | NP_060156.1 | |
GDAP2 | NM_001135589.3 | c.946C>T | p.Gln316Ter | stop_gained | 8/13 | NP_001129061.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GDAP2 | ENST00000369443.10 | c.946C>T | p.Gln316Ter | stop_gained | 8/14 | 2 | NM_017686.4 | ENSP00000358451 | P1 | |
GDAP2 | ENST00000369442.3 | c.946C>T | p.Gln316Ter | stop_gained | 8/13 | 1 | ENSP00000358450 | |||
GDAP2 | ENST00000464026.1 | n.224C>T | non_coding_transcript_exon_variant | 2/5 | 2 | |||||
GDAP2 | ENST00000493555.5 | n.796C>T | non_coding_transcript_exon_variant | 7/7 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152108Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
10
AN:
152108
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000117 AC: 29AN: 247516Hom.: 0 AF XY: 0.0000897 AC XY: 12AN XY: 133726
GnomAD3 exomes
AF:
AC:
29
AN:
247516
Hom.:
AF XY:
AC XY:
12
AN XY:
133726
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000673 AC: 98AN: 1457242Hom.: 0 Cov.: 29 AF XY: 0.0000621 AC XY: 45AN XY: 724776
GnomAD4 exome
AF:
AC:
98
AN:
1457242
Hom.:
Cov.:
29
AF XY:
AC XY:
45
AN XY:
724776
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152108Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74282
GnomAD4 genome
AF:
AC:
10
AN:
152108
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
74282
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
10
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Spinocerebellar ataxia, autosomal recessive 27 Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 28, 2019 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Centogene AG - the Rare Disease Company | Sep 24, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
MutationTaster
Benign
A;A
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at